X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27613) 27613
Magazine Article (93) 93
Book Chapter (88) 88
Newspaper Article (71) 71
Newsletter (28) 28
Book / eBook (15) 15
Book Review (13) 13
Web Resource (8) 8
Government Document (5) 5
Dissertation (3) 3
Trade Publication Article (3) 3
Publication (2) 2
Reference (2) 2
Streaming Video (2) 2
Conference Proceeding (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21496) 21496
male (12998) 12998
female (11332) 11332
cardiac & cardiovascular systems (9930) 9930
animals (8049) 8049
middle aged (7382) 7382
risk factors (6659) 6659
aged (6191) 6191
cardiovascular diseases - chemically induced (5367) 5367
adult (4928) 4928
peripheral vascular disease (3528) 3528
cardiovascular diseases (3510) 3510
cardiovascular disease (3346) 3346
rats (3038) 3038
risk (2938) 2938
treatment outcome (2819) 2819
cardiovascular (2760) 2760
mortality (2698) 2698
time factors (2580) 2580
pharmacology & pharmacy (2522) 2522
hypertension (2259) 2259
hemorrhage - chemically induced (2141) 2141
disease models, animal (2132) 2132
research (2096) 2096
mice (2093) 2093
health aspects (2050) 2050
cardiovascular-disease (2023) 2023
risk assessment (1994) 1994
abridged index medicus (1989) 1989
cardiology (1965) 1965
analysis (1937) 1937
care and treatment (1917) 1917
cardiovascular system (1884) 1884
aged, 80 and over (1882) 1882
heart (1823) 1823
medicine, general & internal (1684) 1684
oxidative stress (1682) 1682
dose-response relationship, drug (1654) 1654
cardiovascular diseases - prevention & control (1634) 1634
therapy (1622) 1622
drug therapy (1616) 1616
retrospective studies (1578) 1578
myocardial-infarction (1567) 1567
diabetes (1557) 1557
physiology (1550) 1550
inflammation (1531) 1531
prevention (1530) 1530
disease (1481) 1481
atherosclerosis (1452) 1452
medicine & public health (1432) 1432
electrocardiography (1394) 1394
anticoagulants - adverse effects (1375) 1375
prospective studies (1341) 1341
stroke (1335) 1335
hematology (1315) 1315
studies (1291) 1291
heart failure (1282) 1282
cardiovascular diseases - epidemiology (1279) 1279
incidence (1272) 1272
adolescent (1271) 1271
follow-up studies (1270) 1270
blood pressure - drug effects (1267) 1267
research article (1255) 1255
medicine (1245) 1245
platelet aggregation inhibitors - adverse effects (1235) 1235
blood pressure (1224) 1224
cancer (1222) 1222
surgery (1200) 1200
heart diseases (1199) 1199
complications and side effects (1182) 1182
toxicology (1182) 1182
hypertension - chemically induced (1180) 1180
rats, sprague-dawley (1159) 1159
physiological aspects (1152) 1152
drug therapy, combination (1142) 1142
heart attacks (1137) 1137
respiratory system (1112) 1112
rodents (1072) 1072
patients (1071) 1071
expression (1032) 1032
aspirin (1026) 1026
randomized controlled trials as topic (1013) 1013
blood-pressure (998) 998
proteins (981) 981
medical research (955) 955
anticoagulants (943) 943
myocardial infarction (940) 940
endocrinology & metabolism (913) 913
thrombosis (906) 906
safety (900) 900
mice, inbred c57bl (897) 897
multidisciplinary sciences (882) 882
cardiac patients (881) 881
pregnancy (881) 881
clinical trials (878) 878
cohort studies (878) 878
usage (873) 873
heart-failure (871) 871
cardiovascular diseases - mortality (866) 866
rats, wistar (855) 855
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (26555) 26555
French (328) 328
German (268) 268
Russian (214) 214
Spanish (172) 172
Japanese (131) 131
Italian (100) 100
Polish (73) 73
Portuguese (44) 44
Dutch (37) 37
Swedish (36) 36
Norwegian (28) 28
Danish (20) 20
Hungarian (17) 17
Czech (16) 16
Chinese (10) 10
Croatian (9) 9
Finnish (9) 9
Romanian (9) 9
Bulgarian (6) 6
Hebrew (6) 6
Korean (4) 4
Turkish (4) 4
Lithuanian (2) 2
Arabic (1) 1
Serbian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
.... SAMS is the most frequent SAS, and mild myalgia may affect 5% to 10% of statin users. Clinically important muscle symptoms, including rhabdomyolysis and statin-induced necrotizing autoimmune myopathy... 
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | C-REACTIVE PROTEIN | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | FORCE 2014 UPDATE | PRIMARY-PREVENTION TRIAL | INDUCED MUSCLE TOXICITY | INTERSTITIAL LUNG-DISEASE | CENTRAL-NERVOUS-SYSTEM | OF-THE-LITERATURE | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 153 - 163
Journal Article
Cardiovascular toxicology, ISSN 1530-7905, 2001
Journal
International journal of dermatology, ISSN 1365-4632, 2010, Volume 49, Issue 3, pp. 239 - 248
Background  Systemic glucocorticoids are used in dermatologic practice for various diseases including connective tissue disorders, bullous diseases, and many other dermatologic conditions... 
MINERAL DENSITY | PREDNISONE TREATMENT | STEROID-INDUCED OSTEOPOROSIS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACTIVE RHEUMATOID-ARTHRITIS | REPLACEMENT THERAPY | LUPUS-ERYTHEMATOSUS | CORTICOSTEROID-INDUCED OSTEOPOROSIS | PEPTIC-ULCER DISEASE | INDUCED BONE LOSS | DERMATOLOGY | Glucocorticoids - therapeutic use | Endocrine System Diseases - chemically induced | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Male | Metabolic Diseases - drug therapy | Osteoporosis - drug therapy | Femur Head Necrosis - drug therapy | Central Nervous System Diseases - prevention & control | Femur Head Necrosis - prevention & control | Gastrointestinal Diseases - drug therapy | Musculoskeletal Diseases - chemically induced | Aged, 80 and over | Female | Endocrine System Diseases - drug therapy | Glucocorticoids - adverse effects | Musculoskeletal Diseases - prevention & control | Musculoskeletal Diseases - drug therapy | Endocrine System Diseases - prevention & control | Osteoporosis - chemically induced | Osteoporosis - prevention & control | Gastrointestinal Diseases - prevention & control | Metabolic Diseases - chemically induced | Skin Diseases - drug therapy | Femur Head Necrosis - chemically induced | Central Nervous System Diseases - chemically induced | Central Nervous System Diseases - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Metabolic Diseases - prevention & control | Gastrointestinal Diseases - chemically induced | Prevention | Complications and side effects | Usage | Care and treatment | Corticosteroids | Skin diseases | Steroids
Journal Article
BMJ : British Medical Journal, ISSN 1756-1833, 7/2014, Volume 349, Issue jul17 11, pp. g3743 - g3743
Statins form the pharmacologic cornerstone of the primary and secondary prevention of atherosclerotic cardiovascular disease... 
STATE OF THE ART REVIEW | LDL CHOLESTEROL | ACUTE KIDNEY INJURY | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | PULMONARY-HYPERTENSION | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | AVERAGE CHOLESTEROL LEVELS | OF-THE-LITERATURE | ERECTILE DYSFUNCTION | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Meta-Analysis as Topic | Cataract - chemically induced | Erectile Dysfunction - chemically induced | Humans | Male | Fatigue - chemically induced | Pancreatitis - prevention & control | Hypercholesterolemia - drug therapy | Transaminases - analysis | Organic Anion Transporters - genetics | Contrast Media - adverse effects | Neoplasms - chemically induced | Kidney Diseases - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Genetic Predisposition to Disease | Kidney Diseases - prevention & control | Risk Factors | Clinical Trials as Topic | Cognition - drug effects | Liver - chemistry | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Dementia - chemically induced | Venous Thromboembolism - chemically induced | Diabetes Mellitus - chemically induced | Chemical and Drug Induced Liver Injury | Polymorphism, Single Nucleotide | Muscular Diseases - genetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Research Design | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2017, Volume 2017, Issue 1, p. CD004143
Background Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women... 
Estrogen Replacement Therapy | Cardiovascular Diseases | Estrogens | Menopause | PREVENTION AND TREATMENT OF LONG TERM PROBLEMS | CLIMACTERIC/MENOPAUSE | Cause of Death | Neoplasms | Randomized Controlled Trials as Topic | Gynaecology | Venous Thromboembolism | Hot Flashes | Postmenopause | Perimenopause | Progesterone | Medicine General & Introductory Medical Sciences | CONJUGATED EQUINE ESTROGENS | BONE-MINERAL DENSITY | Hot Flashes [drug therapy] | Humans | Middle Aged | Neoplasms [chemically induced; mortality] | Venous Thromboembolism [chemically induced] | BASE-LINE CHARACTERISTICS | COLORECTAL-CANCER INCIDENCE | MEDICINE, GENERAL & INTERNAL | Estrogen Replacement Therapy [adverse effects; methods] | Cardiovascular Diseases [chemically induced; mortality] | Adult | Female | QUALITY-OF-LIFE | ESTROGEN PLUS PROGESTIN | CARDIOVASCULAR RISK-FACTORS | MILD COGNITIVE IMPAIRMENT | Estrogens [adverse effects; therapeutic use] | HEALTH INITIATIVE MEMORY | Aged | Progesterone [adverse effects; therapeutic use] | CORONARY-HEART-DISEASE | Hot Flashes - drug therapy | Neoplasms - mortality | Estrogens - adverse effects | Progesterone - adverse effects | Estrogen Replacement Therapy - adverse effects | Estrogens - therapeutic use | Progesterone - therapeutic use | Estrogen Replacement Therapy - methods | Neoplasms - chemically induced | Venous Thromboembolism - chemically induced | Aged, 80 and over | Cardiovascular Diseases - mortality | Cardiovascular Diseases - chemically induced
Journal Article